Insider Transaction Report for Arcellx, Inc.

This filing details insider transactions for Arcellx, Inc. (ACLX) on April 28, 2026. Director Jill Carroll reported the disposition of 1,479,148 shares of Common Stock with a transaction price of $0.00 per share, resulting in 0 shares held post-transaction. Additionally, options to purchase 11,459, 8,011, and 9,174 shares of Common Stock were disposed of with transaction prices of $37.94, $51.30, and $63.68 respectively, also resulting in 0 shares held post-transaction. These transactions are related to the acquisition of Arcellx, Inc. by Gilead Sciences, Inc. and its subsidiary Ravens Sub, Inc. The footnotes indicate that the shares were exchanged for a combination of cash and contingent value rights (CVRs) as part of the merger agreement. The reporting person disclaims beneficial ownership except to the extent of pecuniary interest.